Rho GTPase effectors and NAD metabolism in cancer immune suppression

Mahmoud Chaker, Audrey Minden, Suzie Chen, Robert H Weiss, Eduardo N. Chini, Amit Mahipal, Asfar S. Azmi

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Introduction: Sustained proliferative signaling and de-regulated cellular bioenergetics are two of the chief hallmarks of cancer. Alterations in the Ras pathway and its downstream effectors are among the major drivers for uncontrolled cell growth in many cancers. The GTPases are one of the signaling molecules that activate crucial signal transducing pathways downstream of Ras through several effector proteins. The GTPases (GTP bound) interact with several effectors and modulate a number of different biological pathways including those that regulate cytoskeleton, cellular motility, cytokinesis, proliferation, apoptosis, transcription and nuclear signaling. Similarly, the altered glycolytic pathway, the so-called ‘Warburg effect’, rewires tumor cell metabolism to support the biosynthetic requirements of uncontrolled proliferation. There exists strong evidence for the critical role of the glycolytic pathway’s rate limiting enzymes in promoting immunosuppression. Areas covered: We review the emerging roles of GTPase effector proteins particularly the p21 activated kinase 4 (PAK4) and nicotinamide biosynthetic pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT) as signaling molecules in immune surveillance and the immune response. Expert opinion: In this expert opinion article we highlight the recent information on the role of GTPases and the metabolic enzymes on the immune microenvironment and propose some unique immune therapeutic opportunities.

Original languageEnglish (US)
Pages (from-to)9-17
Number of pages9
JournalExpert Opinion on Therapeutic Targets
Volume22
Issue number1
DOIs
StatePublished - Jan 2 2018

Fingerprint

rho GTP-Binding Proteins
GTP Phosphohydrolases
Metabolism
NAD
Expert Testimony
Neoplasms
Enzymes
Nicotinamide Phosphoribosyltransferase
p21-Activated Kinases
Molecules
Cytokinesis
Niacinamide
Biosynthetic Pathways
Cell growth
Transcription
Guanosine Triphosphate
Cytoskeleton
Immunosuppression
Energy Metabolism
Tumors

Keywords

  • GTPase
  • immune checkpoint
  • NAD
  • NAMPT
  • NAMPT inhibitor
  • NAPRT
  • P21 activated kinases
  • PAK4
  • PAK4 inhibitor
  • PD-1
  • PD-L1
  • Ras

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Rho GTPase effectors and NAD metabolism in cancer immune suppression. / Chaker, Mahmoud; Minden, Audrey; Chen, Suzie; Weiss, Robert H; Chini, Eduardo N.; Mahipal, Amit; Azmi, Asfar S.

In: Expert Opinion on Therapeutic Targets, Vol. 22, No. 1, 02.01.2018, p. 9-17.

Research output: Contribution to journalReview article

Chaker, Mahmoud ; Minden, Audrey ; Chen, Suzie ; Weiss, Robert H ; Chini, Eduardo N. ; Mahipal, Amit ; Azmi, Asfar S. / Rho GTPase effectors and NAD metabolism in cancer immune suppression. In: Expert Opinion on Therapeutic Targets. 2018 ; Vol. 22, No. 1. pp. 9-17.
@article{0b3840edae704de29e58e33b16074cb4,
title = "Rho GTPase effectors and NAD metabolism in cancer immune suppression",
abstract = "Introduction: Sustained proliferative signaling and de-regulated cellular bioenergetics are two of the chief hallmarks of cancer. Alterations in the Ras pathway and its downstream effectors are among the major drivers for uncontrolled cell growth in many cancers. The GTPases are one of the signaling molecules that activate crucial signal transducing pathways downstream of Ras through several effector proteins. The GTPases (GTP bound) interact with several effectors and modulate a number of different biological pathways including those that regulate cytoskeleton, cellular motility, cytokinesis, proliferation, apoptosis, transcription and nuclear signaling. Similarly, the altered glycolytic pathway, the so-called ‘Warburg effect’, rewires tumor cell metabolism to support the biosynthetic requirements of uncontrolled proliferation. There exists strong evidence for the critical role of the glycolytic pathway’s rate limiting enzymes in promoting immunosuppression. Areas covered: We review the emerging roles of GTPase effector proteins particularly the p21 activated kinase 4 (PAK4) and nicotinamide biosynthetic pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT) as signaling molecules in immune surveillance and the immune response. Expert opinion: In this expert opinion article we highlight the recent information on the role of GTPases and the metabolic enzymes on the immune microenvironment and propose some unique immune therapeutic opportunities.",
keywords = "GTPase, immune checkpoint, NAD, NAMPT, NAMPT inhibitor, NAPRT, P21 activated kinases, PAK4, PAK4 inhibitor, PD-1, PD-L1, Ras",
author = "Mahmoud Chaker and Audrey Minden and Suzie Chen and Weiss, {Robert H} and Chini, {Eduardo N.} and Amit Mahipal and Azmi, {Asfar S.}",
year = "2018",
month = "1",
day = "2",
doi = "10.1080/14728222.2018.1413091",
language = "English (US)",
volume = "22",
pages = "9--17",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Rho GTPase effectors and NAD metabolism in cancer immune suppression

AU - Chaker, Mahmoud

AU - Minden, Audrey

AU - Chen, Suzie

AU - Weiss, Robert H

AU - Chini, Eduardo N.

AU - Mahipal, Amit

AU - Azmi, Asfar S.

PY - 2018/1/2

Y1 - 2018/1/2

N2 - Introduction: Sustained proliferative signaling and de-regulated cellular bioenergetics are two of the chief hallmarks of cancer. Alterations in the Ras pathway and its downstream effectors are among the major drivers for uncontrolled cell growth in many cancers. The GTPases are one of the signaling molecules that activate crucial signal transducing pathways downstream of Ras through several effector proteins. The GTPases (GTP bound) interact with several effectors and modulate a number of different biological pathways including those that regulate cytoskeleton, cellular motility, cytokinesis, proliferation, apoptosis, transcription and nuclear signaling. Similarly, the altered glycolytic pathway, the so-called ‘Warburg effect’, rewires tumor cell metabolism to support the biosynthetic requirements of uncontrolled proliferation. There exists strong evidence for the critical role of the glycolytic pathway’s rate limiting enzymes in promoting immunosuppression. Areas covered: We review the emerging roles of GTPase effector proteins particularly the p21 activated kinase 4 (PAK4) and nicotinamide biosynthetic pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT) as signaling molecules in immune surveillance and the immune response. Expert opinion: In this expert opinion article we highlight the recent information on the role of GTPases and the metabolic enzymes on the immune microenvironment and propose some unique immune therapeutic opportunities.

AB - Introduction: Sustained proliferative signaling and de-regulated cellular bioenergetics are two of the chief hallmarks of cancer. Alterations in the Ras pathway and its downstream effectors are among the major drivers for uncontrolled cell growth in many cancers. The GTPases are one of the signaling molecules that activate crucial signal transducing pathways downstream of Ras through several effector proteins. The GTPases (GTP bound) interact with several effectors and modulate a number of different biological pathways including those that regulate cytoskeleton, cellular motility, cytokinesis, proliferation, apoptosis, transcription and nuclear signaling. Similarly, the altered glycolytic pathway, the so-called ‘Warburg effect’, rewires tumor cell metabolism to support the biosynthetic requirements of uncontrolled proliferation. There exists strong evidence for the critical role of the glycolytic pathway’s rate limiting enzymes in promoting immunosuppression. Areas covered: We review the emerging roles of GTPase effector proteins particularly the p21 activated kinase 4 (PAK4) and nicotinamide biosynthetic pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT) as signaling molecules in immune surveillance and the immune response. Expert opinion: In this expert opinion article we highlight the recent information on the role of GTPases and the metabolic enzymes on the immune microenvironment and propose some unique immune therapeutic opportunities.

KW - GTPase

KW - immune checkpoint

KW - NAD

KW - NAMPT

KW - NAMPT inhibitor

KW - NAPRT

KW - P21 activated kinases

KW - PAK4

KW - PAK4 inhibitor

KW - PD-1

KW - PD-L1

KW - Ras

UR - http://www.scopus.com/inward/record.url?scp=85038248827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038248827&partnerID=8YFLogxK

U2 - 10.1080/14728222.2018.1413091

DO - 10.1080/14728222.2018.1413091

M3 - Review article

C2 - 29207896

AN - SCOPUS:85038248827

VL - 22

SP - 9

EP - 17

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 1

ER -